Cargando…

The Effects of Pioglitazone on Bone Formation and Resorption Markers in Type 2 Diabetes Mellitus

OBJECTIVE: The use of thiazolidinediones is reported to be associated with an increased frequency of fractures, especially in women; however, the underlying mechanism is not clear. In this prospective study, we compared the effects of pioglitazone and metformin on bone metabolism in Japanese patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mori, Hiroko, Okada, Yosuke, Tanaka, Yoshiya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5498191/ https://www.ncbi.nlm.nih.gov/pubmed/28566590 http://dx.doi.org/10.2169/internalmedicine.56.8096

Ejemplares similares

Sitagliptin improves albuminuria in patients with type 2 diabetes mellitus
por: Mori, Hiroko, et al.
Publicado: (2013)

Relationship between fluctuations in glucose levels measured by continuous glucose monitoring and vascular endothelial dysfunction in type 2 diabetes mellitus
por: Torimoto, Keiichi, et al.
Publicado: (2013)

Efficacy of α‐glucosidase inhibitors combined with dipeptidyl‐peptidase‐4 inhibitor (alogliptin) for glucose fluctuation in patients with type 2 diabetes mellitus by continuous glucose monitoring
por: Kurozumi, Akira, et al.
Publicado: (2013)

The effect of semelil (angipars®) on bone resorption and bone formation markers in type 2 diabetic patients
por: Hasani-Ranjbar, Shirin, et al.
Publicado: (2012)

Hypoglycemia Abrogates the Vascular Endothelial Protective Effect of Exenatide in Type 2 Diabetes Mellitus
por: Torimoto, Keiichi, et al.
Publicado: (2019)

Associations between urinary 6‐sulfatoxymelatonin excretion and diabetic vascular complications or arteriosclerosis in patients with type 2 diabetes
por: Tanaka, Kenichi, et al.
Publicado: (2020)

Low levels of 1,5-anhydro-D-glucitol are associated with vascular endothelial dysfunction in type 2 diabetes
por: Torimoto, Keiichi, et al.
Publicado: (2014)

Effects of exenatide on postprandial vascular endothelial dysfunction in type 2 diabetes mellitus
por: Torimoto, Keiichi, et al.
Publicado: (2015)

The Effects of Pioglitazone on Biochemical Markers of Bone Turnover in the Patients with Type 2 Diabetes
por: Xiao, Wen-hua, et al.
Publicado: (2013)

A Study of the Vascular Endothelial Function in Patients with Type 2 Diabetes Mellitus and Rheumatoid Arthritis
por: Mori, Hiroko, et al.
Publicado: (2019)

Effect of Pioglitazone on the Course of New-Onset Type 1 Diabetes Mellitus
por: Tafuri, Kimberly Sue, et al.
Publicado: (2013)

Effects of Incretin-Related Diabetes Drugs on Bone Formation and Bone Resorption
por: Kitaura, Hideki, et al.
Publicado: (2021)

Excess Visceral Adipose Tissue Worsens the Vascular Endothelial Function in Patients with Type 2 Diabetes Mellitus
por: Kurozumi, Akira, et al.
Publicado: (2016)

Comparison of effects of anagliptin and alogliptin on serum lipid profile in type 2 diabetes mellitus patients
por: Kurozumi, Akira, et al.
Publicado: (2017)

Factors influencing inter‐day glycemic variability in diabetic outpatients receiving insulin therapy
por: Mori, Hiroko, et al.
Publicado: (2016)

Effect of pioglitazone on serum concentrations of osteoprotegerin in patients with type 2 diabetes mellitus
por: Park, Jong Suk, et al.
Publicado: (2011)

A Comparative Study on the Efficacy and Safety of Dose Escalation of Luseogliflozin in Type 2 Diabetes Mellitus Patients With Poor Glycemic Control
por: Arao, Tadashi, et al.
Publicado: (2023)

Changes in endothelial function during educational hospitalization and the contributor to improvement of endothelial function in type 2 diabetes mellitus
por: Goshima, Yukiko, et al.
Publicado: (2020)

Alogliptin in combination with metformin and pioglitazone for the treatment of type 2 diabetes mellitus
por: Holland, Daniel Q, et al.
Publicado: (2014)

Bone formation and resorption markers at 7 years of age: Relations with growth and bone mineralization
por: Monjardino, Teresa, et al.
Publicado: (2019)

Hypoglycemia in blood glucose level in type 2 diabetic Japanese patients by continuous glucose monitoring
por: Hajime, Maiko, et al.
Publicado: (2019)

Effects of Loganin on Bone Formation and Resorption In Vitro and In Vivo
por: Lee, Chang-Gun, et al.
Publicado: (2022)

The Effects of Mitiglinide and Repaglinide on Postprandial Hyperglycemia in Patients Undergoing Methylprednisolone Pulse Therapy
por: Tanaka, Kenichi, et al.
Publicado: (2017)

Effects of co-administration of candesartan with pioglitazone on inflammatory parameters in hypertensive patients with type 2 diabetes mellitus: a preliminary report
por: Suzuki, Hirofumi, et al.
Publicado: (2013)

Real-world effectiveness of liraglutide versus dulaglutide in Japanese patients with type 2 diabetes: a retrospective study
por: Tanaka, Kenichi, et al.
Publicado: (2022)

Markers of Local Inflammation and Bone Resorption in the Acute Diabetic Charcot Foot
por: Jansen, Rasmus Bo, et al.
Publicado: (2018)

Effects of abaloparatide and teriparatide on bone resorption and bone formation in female mice()
por: Arlt, Heike, et al.
Publicado: (2020)

Interleukin-6 May Not Affect Bone Resorption Marker CTX or Bone Formation Marker P1NP in Humans
por: Lehrskov, Louise L, et al.
Publicado: (2020)

Relationship between renal stone formation, mitral annular calcification and bone resorption markers
por: Celik, Ahmet, et al.
Publicado: (2010)

Finely-Tuned Calcium Oscillations in Osteoclast Differentiation and Bone Resorption
por: Okada, Hiroyuki, et al.
Publicado: (2020)

Efficacy and safety of teneligliptin in combination with pioglitazone in Japanese patients with type 2 diabetes mellitus
por: Kadowaki, Takashi, et al.
Publicado: (2013)

Comparative Efficacy of Lobeglitazone Versus Pioglitazone on Albuminuria in Patients with Type 2 Diabetes Mellitus
por: Kim, Kyung-Soo, et al.
Publicado: (2020)

Pioglitazone for NAFLD Patients With Prediabetes or Type 2 Diabetes Mellitus: A Meta-Analysis
por: Lian, Jingxuan, et al.
Publicado: (2021)

Pioglitazone alters fat distribution in patients with type 2 diabetes mellitus, in contrast to metformin
por: Jonker, Jacqueline T, et al.
Publicado: (2009)

Pioglitazone and sulfonylureas: effectively treating type 2 diabetes
por: Hanefeld, M
Publicado: (2007)

Lower bone mineral density and higher bone resorption marker levels in premenopausal women with type 1 diabetes in Japan
por: Yoshioka, Fumi, et al.
Publicado: (2021)

Protective Effects of Vildagliptin against Pioglitazone-Induced Bone Loss in Type 2 Diabetic Rats
por: Eom, Young Sil, et al.
Publicado: (2016)

Early effects of sodium-glucose co-transporter 2 inhibitors in type 2 diabetes: study based on continuous glucose monitoring
por: Torimoto, Keiichi, et al.
Publicado: (2017)

No changes in levels of bone formation and resorption markers following a broad-spectrum antibiotic course
por: Mikkelsen, Kristian H., et al.
Publicado: (2018)

Corrigendum: Pioglitazone for NAFLD Patients With Prediabetes or Type 2 Diabetes Mellitus: A Meta-Analysis
por: Lian, Jingxuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5759pllanqrovfgh3qeu8bpvgr